These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 5333599)

  • 1. [Studies on mechanism of action of bruneomycin].
    Dudnik IuV; Gauze GG
    Antibiotiki; 1965 Oct; 10(10):880-5. PubMed ID: 5333599
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of bruneomycin action.
    Dudnik YV; Gauze GG
    Fed Proc Transl Suppl; 1966; 25(6):1109-12. PubMed ID: 5333659
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of compounds with both antitumor and bacteriophage-inducing activities on Escherichia coli nucleic acid synthesis.
    Heinemann B; Howard AJ
    Antimicrob Agents Chemother (Bethesda); 1965; 5():488-92. PubMed ID: 5327520
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the mechanisms of action on the bacterial cell of a new antimicrobial drug: nifurzide (author's transl)].
    Videz S; Perrier J; Gounot AM
    Ann Pharm Fr; 1981; 39(5):451-62. PubMed ID: 7034623
    [No Abstract]   [Full Text] [Related]  

  • 5. Interactions of small molecules with nucleic acids. I. Mode of action of anthramycin.
    Horwitz SB; Grollman AP
    Antimicrob Agents Chemother (Bethesda); 1968; 8():21-4. PubMed ID: 4898527
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of netropsin on the growth and biosynthesis of nucleic acids and proteins in Escherichia coli].
    Haupt I; Thrum H
    Z Allg Mikrobiol; 1971; 11(5):457-60. PubMed ID: 4946697
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of action of antitumor agents on bacteria. I. Genetic studies.
    Kumazawa M; Inada S; Tago K
    Kitasato Arch Exp Med; 1974 Sep; 47(3):69-78. PubMed ID: 4617788
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential antibacterial activity of genistein arising from global inhibition of DNA, RNA and protein synthesis in some bacterial strains.
    Ulanowska K; Tkaczyk A; Konopa G; Wegrzyn G
    Arch Microbiol; 2006 Jan; 184(5):271-8. PubMed ID: 16328542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis.
    Ulvatne H; Samuelsen Ø; Haukland HH; Krämer M; Vorland LH
    FEMS Microbiol Lett; 2004 Aug; 237(2):377-84. PubMed ID: 15321686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of the post-antibiotic effects induced by rifampicin and gentamicin in Escherichia coli.
    Stubbings W; Bostock J; Ingham E; Chopra I
    J Antimicrob Chemother; 2006 Aug; 58(2):444-8. PubMed ID: 16735423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of action of sparsomycin in Escherichia coli.
    Slechta L
    Antimicrob Agents Chemother (Bethesda); 1965; 5():326-33. PubMed ID: 5327515
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasmid and drug resistance profile of sorbitol nonfermenting cefixime-tellurite resistant Escherichia coli isolates from the Gomti River.
    Ram S; Shanker R
    Bull Environ Contam Toxicol; 2005 Oct; 75(4):623-8. PubMed ID: 16400540
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the bactericidal action of cephaloridin. Mode of action].
    Bernard J; Lambin S
    Ann Inst Pasteur (Paris); 1965 Dec; 109(6):907-20. PubMed ID: 5322895
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacterial defence against antibiotics.
    Normark S; Bergström S; Edlund T; Grundström T; Jaurin B
    Scand J Infect Dis Suppl; 1980; Suppl 24():188-94. PubMed ID: 7010556
    [No Abstract]   [Full Text] [Related]  

  • 15. Genotypic analysis of Escherichia coli strains from poultry carcasses and their susceptibilities to antimicrobial agents.
    Geornaras I; Hastings JW; von Holy A
    Appl Environ Microbiol; 2001 Apr; 67(4):1940-4. PubMed ID: 11282652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A primary study on the mechanism of action of benzothiazole-rifamycin].
    Xu KY; Wang YS
    Yao Xue Xue Bao; 1984 Dec; 19(12):881-7. PubMed ID: 6085780
    [No Abstract]   [Full Text] [Related]  

  • 17. First description of blaCTX-M-1-carrying Escherichia coli isolates in Danish primary food production.
    Aarestrup FM; Hasman H; Agersø Y; Jensen LB; Harksen S; Svensmark B
    J Antimicrob Chemother; 2006 Jun; 57(6):1258-9. PubMed ID: 16597635
    [No Abstract]   [Full Text] [Related]  

  • 18. Enterobacterial repetitive intergenic consensus-polymerase chain reaction for typing of uropathogenic Escherichia coli is not what it seems.
    Chulain MN; Morris D; Cormican M
    Clin Infect Dis; 2006 Jun; 42(12):1805-6. PubMed ID: 16705591
    [No Abstract]   [Full Text] [Related]  

  • 19. The antimicrobial peptide polyphemusin localizes to the cytoplasm of Escherichia coli following treatment.
    Powers JP; Martin MM; Goosney DL; Hancock RE
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1522-4. PubMed ID: 16569873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A di-thiocarbamido derivative of 2,2'-biphenylenyl-iodonium salt as a potent antibacterial agent.
    Gennimata D; Kotali E; Varvoglis A; Kyriakidis DA; Tsiftsoglou AS
    J Chemother; 1989 Jul; 1(4 Suppl):229-32. PubMed ID: 16312381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.